PMDA drug package insert
カンデサルタン錠2mg「武田テバ」
PMDA Prescription drug · T'sファーマ株式会社 · package insert Aug 31, 2026
Key facts
| Brand names | カンデサルタン錠2mg「武田テバ」, カンデサルタン錠4mg「武田テバ」, カンデサルタン錠8mg「武田テバ」, カンデサルタン錠12mg「武田テバ」 |
|---|---|
| Nonproprietary names | カンデサルタン シレキセチル |
| Companies | 製造販売元／T'sファーマ株式会社, 販売／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 持続性アンジオテンシンⅡ受容体拮抗剤 |
| Therapeutic category codes | 872149, 872179 |
| YJ codes | 2149040F1379, 2149040F2375, 2149040F3371, 2149040F4378 |
| Approval numbers | 30300AMX00327, 30300AMX00328, 30300AMX00329, 30300AMX00330 |
| Package insert edition | 第6版 |
| Package insert date | Aug 31, 2026 |
| PMDA document key | 400813_2149040F1379_1 |
| PMDA company code | 400813 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: